Citybuzz

Citybuzz

Citybuzz is a vibrant local lifestyle and news media outlet. While primarily reporting on community events and entertainment it also actively covers business innovation and tech trends acting as a window connecting local audiences with modern digital lifestyle trends.

Citybuzz's Articles

Blue Cap AG Shareholders Approve Record Dividend of EUR 1.60 Per Share, Including Special Dividend from con-pearl Exit

Blue Cap AG Shareholders Approve Record Dividend of EUR 1.60 Per Share, Including Special Dividend from con-pearl Exit

Blue Cap AG shareholders approve record dividend of EUR 1.60 per share, including special dividend from con-pearl exit. Janoschka acquisition marks new growth phase

Delivery Hero Shareholders Approve All Resolutions at 2026 AGM, Re-elect Supervisory Board Members

Delivery Hero Shareholders Approve All Resolutions at 2026 AGM, Re-elect Supervisory Board Members

Delivery Hero SE concludes 2026 AGM with unanimous approval of all resolutions, re-election of Scott Ferguson and Roger Rabalais to Supervisory Board, and new auditor

Heidelberg Pharma Shareholders Approve All Agenda Items at 2026 Annual General Meeting, Elect Jack Yefei Ling to Supervisory Board

Heidelberg Pharma Shareholders Approve All Agenda Items at 2026 Annual General Meeting, Elect Jack Yefei Ling to Supervisory Board

Heidelberg Pharma AG reports 98.67% approval at 2026 Annual General Meeting, elects Jack Yefei Ling to Supervisory Board, and advances ATAC technology for cancer

STRATEC Shareholders Approve Dividend of EUR 0.60 per Share at Annual General Meeting

STRATEC Shareholders Approve Dividend of EUR 0.60 per Share at Annual General Meeting

STRATEC SE Annual General Meeting approves EUR 0.60 dividend, PwC as auditor, and all resolutions with 70.1% shareholder representation. Learn more at www.stratec

Voyageur Pharmaceuticals Hires Fluor for Feasibility Studies on Iodine Production and Contrast Drug Facility

Voyageur Pharmaceuticals Hires Fluor for Feasibility Studies on Iodine Production and Contrast Drug Facility

Voyageur Pharmaceuticals engages Fluor for feasibility studies on iodine extraction and integrated contrast drug manufacturing, advancing North America's medical

Datavault AI’s WiSA Technology Powers Goldhorn’s New Home Audio Systems

Datavault AI’s WiSA Technology Powers Goldhorn’s New Home Audio Systems

Datavault AI (DVLT) expands WiSA wireless audio into Goldhorn's Goho LS7 home audio and karaoke systems with 4K projectors, now available in China. Learn how this

Greenland Energy Advances Jameson Project Amid Greenland’s Push for Economic Independence

Greenland Energy Advances Jameson Project Amid Greenland’s Push for Economic Independence

Greenland Energy (NASDAQ: GLND) advances Jameson Project in East Greenland, targeting Arctic resource development to boost economic self-sufficiency. Learn about

Cardio Diagnostics Targets $393B Heart Disease Problem with Epigenetics and AI

Cardio Diagnostics Targets $393B Heart Disease Problem with Epigenetics and AI

Cardio Diagnostics Holdings (NASDAQ: CDIO) uses AI and epigenetics to detect coronary heart disease from a blood draw, targeting a $393 billion problem. Learn how

Nathan Macintosh Brings Two Nights of Stand-Up Comedy to Milwaukee Improv July 2 and 3

Nathan Macintosh Brings Two Nights of Stand-Up Comedy to Milwaukee Improv July 2 and 3

Comedian Nathan Macintosh will perform two nights at Milwaukee Improv in Brookfield, Wisconsin, on July 2 and July 3, 2026. The New York-based comic ha

HeartBeam Launches Pilot Study for On-Demand 12-Lead ECG Patch Aimed at Ischemia Detection

HeartBeam Launches Pilot Study for On-Demand 12-Lead ECG Patch Aimed at Ischemia Detection

HeartBeam (NASDAQ: BEAT) launches pilot study for on-demand 12-lead ECG patch to detect coronary artery disease and ischemia, potentially disrupting the $2 billion